Welcome to our dedicated page for Blade Air Mobility news (Ticker: BLDE), a resource for investors and traders seeking the latest updates and insights on Blade Air Mobility stock.
Blade Air Mobility, Inc. reported developments for a technology-powered air mobility platform that provided hospital air transportation and logistics, including human organ transport, and passenger helicopter and fixed-wing services in the Northeast United States and Southern Europe. Recurring updates covered operating results, medical revenue trends, conference presentations, and the company's asset-light service model supported by terminal infrastructure and proprietary technologies.
Company news also addressed electric aviation integration, including collaboration with advanced air mobility manufacturers and participation in an electric passenger flight. After the completed sale of the Passenger business and the name change to Strata Critical Medical, the public-company story centers on critical medical logistics and clinical services.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Blade Air Mobility, Inc. (Nasdaq: BLDE) will announce its financial results for Q1 2023 on May 11, 2023, prior to market opening. A conference call will follow at 8:00 am ET, hosted by CEO Rob Wiesenthal and CFO Will Heyburn, featuring a Q&A session. Blade, known for its air mobility platform, primarily employs helicopters and amphibious aircraft and is a leading air medical transporter for organ transplants. The company aims to reduce travel friction with cost-effective air transportation while transitioning to Electric Vertical Aircraft (EVA) technology for quieter, emission-free mobility. Investors can access the call through registration, with subsequent webcasts available for one year.
The Board of Directors of Blade Air Mobility, Inc. (NASDAQ: BLDE) has expanded from seven to nine members with the appointments of Andrew Lauck and John Borthwick. Lauck, a Board observer and aviation expert, will join the Audit Committee, while Borthwick, a former Board member, will serve on the Nominating and Corporate Governance Committee. Their expertise aims to support Blade's growth in Passenger and Medical air transport services, enhancing operational efficiency and data insights. The company is currently experiencing strong demand for its services, leveraging its competitive advantages in technology and infrastructure.